Elacestrant dihydrochloride is an orally available, selective estrogen receptor degrader (SERD) used as a pharmaceutical raw material. It functions by binding to the estrogen receptor and inducing its proteasomal degradation, thereby inhibiting estrogen receptor-mediated signaling in cancer cells.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1349723-93-8
Elacestrant
pharmaceutical raw material
Elacestrant Impurity 14
pharmaceutical intermediate
Methyclothiazide
pharmaceutical raw material
(2S)-5,6,7,8-tetrahydrofolic acid
pharmaceutical raw material
(±)-clopidogrel bisulfate
pharmaceutical raw material
Grazoprevir monohydrate
pharmaceutical raw material
(6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol;dihydrochloride
XGFHYCAZOCBCRQ-FBHGDYMESA-N
CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)[C@@H]3CCC4=C(C3)C=CC(=C4)O.Cl.Cl